American Academy of HIV Medicine “Member Conversations: Q&A with Dr. Dovie Watson” , Interview. American Academy of HIV Medicine.: 2026
Meanley S, Listerud L, Kosciow B, Richards A, Watson DL, Frank I, Cantos VD, Doblecki-Lewis S, Brown LB, Hojilla JC, Carter C, Bauermeister JA. Integrating gender-affirming hormone therapy with twice-yearly subcutaneous lenacapavir for HIV prevention: longitudinal qualitative insights from transgender and nonbinary PURPOSE 2 participants. [Paper Presentation] , AIDS 2026: 2026
Meanley S, Listerud L, Richards A, Kosciow B, Watson D, Frank I, Cantos VD, Doblecki-Lewis S, Brown LB, Hojilla JC, Carter C, Bauermeister JA. Endorsement and anticipated challenges to adopting twice-yearly lenacapavir for HIV pre-exposure prophylaxis (PrEP) among cisgender men who have sex with men: qualitative insights from the PURPOSE 2 trial. [Oral Presentation] , AIDS 2026: 2026
Bonett S, Sweeney A, Li Q, Watson DL, Bauermeister J, Hernandez B, Williams J, Brady KA Facilitators and barriers to equitable implementation of telehealth PrEP delivery: A qualitative descriptive study of program staff and stakeholders , Health Promot Pract, 27(3): 2026,564-575
Bauermeister JA, Choi SK, Lin W, Mulawa MI, Hirshfield S, Watson DL, Aryal S, Rochelle AE, Williams A, Crews C, Buckner N, Hightow-Weidman LB, Muessig KE. Evaluating a Smartphone Intervention to Improve HIV Prevention and Care Outcomes: Results from the HealthMPowerment National Randomized Controlled Trial , BMC Public Health: 2026
Lin Willey Yi-Zhi, Choi Seul Ki, Hirshfield S, Mulawa MI, Watson DL, Hightow-Weidman LB, Muessig KE, Bauermeister JA. Recruitment Source and Participant Retention in a Digital HIV Prevention Intervention for Young Black and Latino Men and Transgender Women: Secondary Analysis of the HealthMpowerment 2.0 Randomized Controlled Trial. , JMIR Form Res., 10: 2026,e75793
Bonett S, Sweeney A, Correa N, Li Q, Hernandez B, Watson DL, Williams J, Brady KA, Gaither-Hardy D, Joffe A, Safa H. Implementation determinants and outcomes in the Philadelphia TelePrEP Program: a mixed methods study of client and staff perspectives. , Implement Sci Commun, 7: 2026
Simon L, Beals D, Pogroszewski S, Washington T, Deerr R, Watson DL, Serota DP, Sherbuk JE, Somboonwith C. P-2081. Lessons Learned from Diverse Community Screenings and Client, Clinician, and Stakeholder Education to Improve HIV Detection in Priority Populations. [Paper Presentation] , IDWeek 2025: 2025
Meanley S, Listerud L, Kosciow B, Richards A, Bauermeister JA, Watson DL, Hiserodt E, Rocha D, Parchment A, Arnold E, Bouris A Overcoming salient barriers to PrEP use among Black and Latino cisgender men who have sex with men: Provider and patient perspectives on patient-centered PrEP care. [Paper Presentation] , American Academy of Health Behavior 2025 Scientific Meeting: 2025
Watson DL, Listerud L, Drab R, Lin WL, Momplaisir F, Bauermeister JA HIV PrEP Method Preferences Among Transgender and Gender-Diverse Adults in the United States. [Paper Presentation] , Conference on Retroviruses and Opportunistic Infections: 2025
